← FDA Drug Approvals (Drugs@FDA)

NALOXONE HYDROCHLORIDE (AUTOINJECTOR)

NDA · New Drug Application · Sponsor: KALEO INC · Approved 2022-02-28

Drug application

FDA Application #

NDA215457

Application type

New Drug Application

Brand name

NALOXONE HYDROCHLORIDE (AUTOINJECTOR)

Generic name

NALOXONE HYDROCHLORIDE

Active ingredients

NALOXONE HYDROCHLORIDE

Dosage form

SOLUTION

Route

INTRAMUSCULAR, SUBCUTANEOUS

Marketing status

Discontinued

Sponsor

KALEO INC

Manufacturer

Kaleo, Inc.

First approval

2022-02-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown